0002130381-26-000001.txt : 20260420 0002130381-26-000001.hdr.sgml : 20260420 20260420130340 ACCESSION NUMBER: 0002130381-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260420 DATE AS OF CHANGE: 20260420 EFFECTIVENESS DATE: 20260420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PCR Land Fund II, LP CENTRAL INDEX KEY: 0002130381 ORGANIZATION NAME: EIN: 421915601 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-581103 FILM NUMBER: 26874328 BUSINESS ADDRESS: STREET 1: 5847 SAN FELIPE ST., SUITE 1400 CITY: HOUSTON STATE: TX ZIP: 77057 BUSINESS PHONE: 713-629-0500 MAIL ADDRESS: STREET 1: 5847 SAN FELIPE ST., SUITE 1400 CITY: HOUSTON STATE: TX ZIP: 77057 D 1 primary_doc.xml X0708 D LIVE 0002130381 PCR Land Fund II, LP 5847 SAN FELIPE ST., SUITE 1400 HOUSTON TX TEXAS 77057 713-629-0500 TEXAS None None Limited Partnership true 2026 n/a PCR LAND FUND II GP, LLC 5847 SAN FELIPE ST., SUITE 1400 HOUSTON TX TEXAS 77057 Director Promoter General Partner of Issuer. n/a PCR LAND INVESTMENTS, LLC 5847 SAN FELIPE ST., SUITE 1400 HOUSTON TX TEXAS 77057 Executive Officer Promoter Investment Manager of Issuer. Other Real Estate Decline to Disclose 06b false true true true true false 100000 PCR FINANCE GROUP, LLC 315067 None None 5847 SAN FELIPE ST, SUITE 1400 HOUSTOn TX TEXAS 77057 AL ALABAMA CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE FL FLORIDA GA GEORGIA KS KANSAS LA LOUISIANA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA OH OHIO PA PENNSYLVANIA SC SOUTH CAROLINA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA false 25000000 0 25000000 false 0 500000 true 0 The placement agent will receive a fee that is equal to up to 2% of the amounts sold. 0 Affiliates of the Issuer's Investment Manager are entitled to certain fees and an affiliate of the Issuer's General Partner is entitled to a carried interest, all of which are disclosed in the Issuer's confidential offering materials. false PCR Land Fund II, LP /s/ Mark Andrew Pappas Mark Andrew Pappas Manager of GP of Issuer 2026-04-20